Collegium Pharmaceutical, Inc. Capital Expenditures
Collegium Pharmaceutical, Inc. (COLL) reported Capital Expenditures of $766.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $496.00K, a 663.08% increase year-over-year.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $270.00K, a 66.17% decline year-over-year.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $689.00K, a 20.88% increase year-over-year.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $188.00K, a 22.95% decline year-over-year.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.74M, a 5.33% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.65M, a 258.35% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $461.00K, a 71.58% decline from fiscal 2022.
- Collegium Pharmaceutical, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.62M, a 16.56% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $766.00K 10-Q · filed 2026-08-06 | $1.46M derived: sum of 3 quarters · filed 2026-08-06 | $1.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $270.00K 10-Q · filed 2026-05-07 | $959.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.15M derived: sum of 3 quarters · filed 2026-05-07 | $1.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $877.00K derived: sum of 2 quarters · filed 2026-02-26 | $942.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.74M 10-K · filed 2026-02-26 |
| 2025-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $253.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.05M 10-Q · filed 2025-11-06 | $1.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $863.00K 10-Q · filed 2026-08-06 | $1.43M derived: sum of 3 quarters · filed 2026-08-06 | $1.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $798.00K 10-Q · filed 2026-05-07 | $1.37M derived: sum of 2 quarters · filed 2026-05-07 | $1.61M derived: sum of 3 quarters · filed 2026-05-07 | $1.88M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $814.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.08M derived: sum of 3 quarters · filed 2026-02-26 | $1.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $514.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.08M 10-Q · filed 2025-11-06 | $1.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $838.00K 10-Q · filed 2025-08-07 | $1.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.07M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $568.00K 10-Q · filed 2025-05-08 | $732.00K derived: sum of 2 quarters · filed 2026-02-26 | $797.00K derived: sum of 3 quarters · filed 2026-02-26 | $853.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $229.00K derived: sum of 2 quarters · filed 2026-02-26 | $285.00K derived: sum of 3 quarters · filed 2026-02-26 | $461.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $121.00K derived: sum of 2 quarters · filed 2024-11-07 | $297.00K 10-Q · filed 2024-11-07 | $1.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $232.00K 10-Q · filed 2024-08-08 | $1.17M derived: sum of 3 quarters · filed 2025-02-27 | $1.28M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $176.00K 10-Q · filed 2024-05-09 | $1.12M derived: sum of 2 quarters · filed 2025-02-27 | $1.23M derived: sum of 3 quarters · filed 2025-02-27 | $1.69M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.05M derived: sum of 2 quarters · filed 2025-02-27 | $1.51M derived: sum of 3 quarters · filed 2025-02-27 | $1.62M 10-K · filed 2025-02-27 |
| 2022-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $574.00K derived: sum of 2 quarters · filed 2023-11-07 | $682.00K 10-Q · filed 2023-11-07 | $1.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $569.00K 10-Q · filed 2023-08-03 | $1.08M derived: sum of 3 quarters · filed 2024-02-22 | $1.36M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $108.00K 10-Q · filed 2023-05-04 | $623.00K derived: sum of 2 quarters · filed 2024-02-22 | $899.00K derived: sum of 3 quarters · filed 2024-02-22 | $1.62M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $791.00K derived: sum of 2 quarters · filed 2024-02-22 | $1.52M derived: sum of 3 quarters · filed 2024-02-22 | $1.94M 10-K · filed 2024-02-22 |
| 2021-09-30 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.43M 10-Q · filed 2022-11-03 | $2.91M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.15M 10-Q · filed 2022-08-04 | $2.63M derived: sum of 3 quarters · filed 2023-02-23 | $5.04M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $428.00K 10-Q · filed 2022-05-10 | $1.91M derived: sum of 2 quarters · filed 2023-02-23 | $4.31M derived: sum of 3 quarters · filed 2023-02-23 | $5.14M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.88M derived: sum of 2 quarters · filed 2023-02-23 | $4.71M derived: sum of 3 quarters · filed 2023-02-23 | $5.55M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.23M derived: sum of 2 quarters · filed 2021-11-04 | $4.07M 10-Q · filed 2021-11-04 | $4.95M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $826.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.66M 10-Q · filed 2021-08-05 | $2.55M derived: sum of 3 quarters · filed 2022-02-24 | $3.90M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $836.00K 10-Q · filed 2021-05-06 | $1.73M derived: sum of 2 quarters · filed 2022-02-24 | $3.08M derived: sum of 3 quarters · filed 2022-02-24 | $3.95M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.24M derived: sum of 2 quarters · filed 2022-02-24 | $3.12M derived: sum of 3 quarters · filed 2022-02-24 | $6.44M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.23M derived: sum of 2 quarters · filed 2020-11-05 | $5.55M 10-Q · filed 2020-11-05 | $7.32M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $875.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.20M 10-Q · filed 2020-08-05 | $5.97M derived: sum of 3 quarters · filed 2021-02-25 | $8.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $3.32M 10-Q · filed 2020-05-07 | $5.10M derived: sum of 2 quarters · filed 2021-02-25 | $7.81M derived: sum of 3 quarters · filed 2021-02-25 | $8.44M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.49M derived: sum of 2 quarters · filed 2021-02-25 | $5.12M derived: sum of 3 quarters · filed 2021-02-25 | $5.48M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $3.35M derived: sum of 2 quarters · filed 2019-11-06 | $3.70M 10-Q · filed 2019-11-06 | $3.88M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $987.00K 10-Q · filed 2019-08-07 | $1.16M derived: sum of 3 quarters · filed 2020-02-27 | $1.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $356.00K 10-Q · filed 2019-05-08 | $528.00K derived: sum of 2 quarters · filed 2020-02-27 | $868.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.32M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $512.00K derived: sum of 2 quarters · filed 2020-02-27 | $961.00K derived: sum of 3 quarters · filed 2020-02-27 | $990.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $789.00K derived: sum of 2 quarters · filed 2018-11-08 | $818.00K 10-Q · filed 2018-11-08 | $1.16M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $478.00K 10-Q · filed 2018-08-08 | $819.00K derived: sum of 3 quarters · filed 2019-02-27 | $930.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $29.00K 10-Q · filed 2018-05-09 | $370.00K derived: sum of 2 quarters · filed 2019-02-27 | $481.00K derived: sum of 3 quarters · filed 2019-02-27 | |
| 2016-12-31 | $341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $452.00K derived: sum of 2 quarters · filed 2019-02-27 | $477.00K 10-K · filed 2019-02-27 | |
| 2016-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $136.00K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $25.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $339.00K derived: sum of 2 quarters · filed 2018-03-07 | $362.00K 10-K · filed 2018-03-07 | |
| 2015-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $175.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $23.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $8.00K 10-K · filed 2017-03-10 | |||
| 2013-12-31 | $206.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |